Erythropoietin linked to improved hemoglobin levels in knee or hip arthroplasty

11/13/2013 | Healio (free registration)

Use of erythropoietin-stimulating agents before elective knee and hip arthroplasty is linked to higher hemoglobin levels and reduced need for allogeneic blood transfusion, according to a new review. Results of the study published in the Journal of Arthroplasty showed a mean hemoglobin level increase of 7.16 grams per liter among those who received ESA, and the authors reported no difference in the risk of thromboembolism.

View Full Article in:

Healio (free registration)

Published in Brief:

SmartBrief Job Listings for Health Care

Job Title Company Location
Legal Counsel
Alcon
Fort Worth, TX
Director, Senior Legal Counsel
Alcon
Fort Worth, TX
Corporate Counsel - Healthcare Law Group
Genentech
South San Francisco, CA
Manager/Senior Manager, Health Services Analytics
Avalere Health
Washington, DC
Manager/Senior Manager, Health Economist
Avalere Health
Washington, DC